Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck’s Keytruda receives accelerated FDA approval for GEJ adenocarcinoma

pharmaceufical-technologySeptember 26, 2017

Tag: Merck’s Keytruda , GEJ adenocarcinoma , FDA

PharmaSources Customer Service